Gamma-glutamyltransferase predicts macrovesicular liver graft steatosis – an analysis of discarded liver allografts in Finland

References

• Linares I, Hamar M, Selzner N, et al. Steatosis in liver transplantation: current limitations and future strategies. Transplantation. 2019;103(1):78–90.
   PubMed Web of Science ®Google Scholar
• Hoyer DP, Paul A, Gallinat A, et al. Donor information based prediction of early allograft dysfunction and outcome in liver transplantation. Liver Int. 2015;35(1):156–163.
   PubMed Web of Science ®Google Scholar
• Perez-Daga JA, Santoyo J, Suárez MA, et al. Influence of degree of hepatic steatosis on graft function and postoperative complications of liver transplantation. Transplant Proc. 2006;38(8):2468–2470.
   PubMed Web of Science ®Google Scholar
• McCormack L, Petrowsky H, Jochum W, et al. Use of severely steatotic grafts in liver transplantation: a matched case-control study. Ann Surg. 2007;246(6):940.
   PubMed Web of Science ®Google Scholar
• Spitzer AL, Lao OB, Dick AAS, et al. The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment. Liver Transpl. 2010;16(7):874–884.
   PubMed Web of Science ®Google Scholar
• de Graaf EL, Kench J, Dilworth P, et al. Grade of decreased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the donor risk index. J Gastroenterol Hepatol. 2012;27(3):540–546.
   PubMed Web of Science ®Google Scholar
• Gwiasda J, Schrem H, Klempnauer J, et al. Kalten bron A. identifying independent risk factors for graft loss after primary liver transplantation. Langenbecks Arch Surg. 2017;402(5):757–766.
   PubMed Web of Science ®Google Scholar
• Fishbein TM, Fiel MI, Emre S, et al. Use of livers with microvesicular fat safely expands the donor Pool. Transplantation. 1997;64(2):248–251.
   PubMed Web of Science ®Google Scholar
• Gabrielli M, Moisan F, Vidal M, et al. Steatotic livers. Can we use them in OLTX? Outcome data from prospective baseline liver biopsy study. Ann Hepatol. 2012;11(6):891–898.
   PubMed Web of Science ®Google Scholar
• Andert A, Ulmer TF, Schöning W, et al. Grade of donor liver microvesicular steatosis does not affect the postoperative outcome after liver transplantation. Hepatobiliary Pancreat Dis Int. 2017;16(6):617–623.
   PubMed Web of Science ®Google Scholar
• Croome KP, Lee DD, Croome S, et al. Does donor allograft microsteatosis matter? Comparison of outcomes in liver transplantation with a propensity-matched cohort. Liver Transpl. 2019;25(10):1533–1540.
   PubMed Web of Science ®Google Scholar
• Adam R, Reynes M, Johann M, et al. The outcome of steatotic grafts in liver transplantation. Transplant Proc. 1991;23(1 Pt 2):1538–1540.
   PubMed Web of Science ®Google Scholar
• Ricci C, Longo R, Gioulis E, et al. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol. 1997;27(1):108–113.
   PubMed Web of Science ®Google Scholar
• Park SH, Kim PN, Kim KW, et al. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology. 2006;239(1):105–112.
   PubMed Web of Science ®Google Scholar
• Croome KP, Lee DD, Taner CB. The “skinny” on assessment and utilization of steatotic liver grafts: a systematic review. Liver Transpl. 2019;25(3):488–499.
   PubMed Web of Science ®Google Scholar
• Rogier J, Roullet S, Cornélis F, et al. Noninvasive assessment of macrovesicular liver steatosis in cadaveric donors based on computed tomography liver-to-spleen attenuation ratio. Liver Transpl. 2015;21(5):690–695.
   PubMed Web of Science ®Google Scholar
• Westerbacka J, Cornér A, Tiikkainen M, et al. Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia. 2004;47(8):1360–1369.
   PubMed Web of Science ®Google Scholar
• Yersiz H, Lee C, Kaldas FM, et al. Assessment of hepatic steatosis by transplant surgeon and expert pathologist: a prospective, double-blind evaluation of 201 donor livers. Liver Transpl. 2013;19(4):437–449.
   PubMed Web of Science ®Google Scholar
• Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci. 2001;38(4):263–355.
   PubMed Web of Science ®Google Scholar
• Armstrong MJ, Houlihan DD, Bentham L, et al. Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort. J Hepatol. 2012;56(1):234–240.
   PubMed Web of Science ®Google Scholar
• Bedogni G, Bellentani S, Miglioli L, et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6(1):33–40.
   PubMed Web of Science ®Google Scholar
• Kunutsor SK, Apekey A, Seddoh D. Gamma glutamyltransferase and metabolic syndrome risk: a systematic review and dose-response meta-analysis. Int J Clin Pract. 2015;69(1):136–144.
   PubMed Web of Science ®Google Scholar
• Sillanaukee P, Massot N, Jousilahti P, et al. Dose response of laboratory markers to alcohol consumption in a general population. Am J Epidemiol. 2000;152(8):747–751.
   PubMed Web of Science ®Google Scholar
• Niemelä O. Biomarker-based approaches for assessing alcohol use disorders. Int J Environ Res Public Health. 2016;13(2):166–185.
   PubMed Web of Science ®Google Scholar
• Wu A, Slavin G, Levi AJ. Elevated serum gamma glutamyl transferase (transpeptidase) and histological liver damage in alcoholism. Am J Gastroenterol. 1976;65(4):318–323.
   PubMed Web of Science ®Google Scholar
• Kryszewski A, Bardzik I, Kilkowska K, et al. Gamma-glutamyl transpeptidase activity in serum and liver in chronic alcoholism. Possible usefulness as a test of abstinence. Acta Med Polonica. 1977;18:199–211.
   PubMedGoogle Scholar
• Chu MJJ, Dare AJ, Phillips ARJ, et al. Donor hepatic steatosis and outcome after liver transplantation: a systematic review. J Gastrointest Surg. 2015;19(9):1713–1724.
   PubMed Web of Science ®Google Scholar
• Northup PG, Intagliata NM, Davis JPE, et al. Macrosteatotic allografts and obese recipients have nearly equal negative impact on liver transplant survival. Transplantation. 2020;104(6):1193–1200.
   PubMed Web of Science ®Google Scholar
• Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of donor risk index. Am J Transplant. 2006;6(4):783–790.
   PubMed Web of Science ®Google Scholar
• Braat AE, Blok JJ, Putter H, et al. The eurotransplant donor risk index in liver transplantation: ET-DRI. Am J Transplant. 2012;12(10):2789–2796.
   PubMed Web of Science ®Google Scholar
• Åberg F, Nordin A, Mäkisalo H, et al. Who is too healthy and who is too sick for liver transplantation: external validation of prognostic scores and survival benefit estimation? Scand J Gastroenterol. 2015;50(9):1144–1151.
   PubMed Web of Science ®Google Scholar
• Winter A, Féray C, Audureau E, et al. External validation of the donor risk index and the eurotranplant donor risk index on the french liver transplant registry. Liver Int. 2017;37(8):1229–1238.
   PubMed Web of Science ®Google Scholar